{"id":"W4296010496","doi":"10.1016/j.annonc.2022.07.857","title":"731MO A phase I trial of the bifunctional EGFR/TGFβ fusion protein BCA101 alone and in combination with pembrolizumab in patients with advanced solid tumors","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Colorectal and Anal Carcinomas","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Pembrolizumab; Tolerability; Internal medicine; Rash; Gastroenterology; Phases of clinical research; Expanded access; Oncology; Refractory (planetary science); Surgery; Adverse effect; Cancer; Clinical trial; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002327417,0.00008412504,0.0003439434,0.0001657154,0.00004435689,0.00000119646,0.00005269354,0.00003429282,0.00006416746],"category_scores_gemma":[0.00006554625,0.00005399905,0.00003216499,0.0003650335,0.0001124829,0.00004862325,0.00007269382,0.0001948697,1.712854e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000640787,"about_ca_system_score_gemma":0.0002472925,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009781207,"about_ca_topic_score_gemma":0.000235731,"domain_scores_codex":[0.9989951,0.0001391374,0.0002810092,0.0001579434,0.0002932568,0.0001335553],"domain_scores_gemma":[0.9994672,0.00004903026,0.0002250217,0.00009398908,0.0001300481,0.00003473865],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8165157,0.01284642,0.122452,0.0001273308,0.00005185588,0.0000795247,0.0008358044,0.0001931993,0.009609292,0.0002202117,0.0001114132,0.03695716],"study_design_scores_gemma":[0.2592459,0.09685264,0.6391702,0.0001424963,0.00002872162,0.00004073434,0.0003463391,0.0002055783,0.003002862,0.000252103,0.0006050682,0.0001074259],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964611,0.00003664693,0.000001465375,0.001758942,0.00004298569,0.001176026,0.00001257283,0.000003684548,0.000506606],"genre_scores_gemma":[0.9995179,0.000004256533,0.00002630602,0.000178851,0.00001371341,0.0001348728,0.00002821733,0.000007040916,0.00008884311],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5572699,"threshold_uncertainty_score":0.2202017,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02320620779014601,"score_gpt":0.3092899193212572,"score_spread":0.2860837115311112,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}